Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04053686
Other study ID # 2019ISPAR008
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 9, 2019
Est. completion date December 20, 2019

Study information

Verified date November 2020
Source University of Bedfordshire
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time in full-time police staff. The secondary aims of this study are to assess preliminary effects on patterns of sedentary behaviour (number of breaks, number of prolonged sitting bouts, average duration of prolonged sitting bouts, and total prolonged sitting duration), additional measures of sedentary behaviour (total sitting time, standing, and stepping), cardiometabolic risk markers, physiological stress (cortisol levels), physical health (self-report and postural stability), psychological wellbeing and mood, work stress (self-reported), and work performance (job satisfaction and productivity).


Description:

Prolonged sedentary behaviour is associated with a higher incidence of cardiovascular disease and type 2 diabetes. A large proportion of daily sedentary time (sitting) occurs in the workplace. On average, full time office workers spend upwards of 70% of their working day seated with the majority of this time accumulated in sitting bouts ≥ 20 minutes. A recent cross-sectional investigation into the occupational characteristics of over 5,000 British police force employees reported at least 30% identifying as having mainly office-based duties. When trying to reduce prolonged sitting in the workplace, one of the most effective strategies is the use of multi-component interventions. At the present time, sedentary workplace intervention studies in the police are limited. The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time at work in full-time police staff. The secondary aims of this study are to assess preliminary effects on sedentary behaviour, cardiometabolic risk markers, physiological stress, physical health, psychological wellbeing and mood, work stress, and work performance. This has a single-arm, pre-post study design. Participants will receive a multi-component intervention to break up and reduce prolonged sitting including: a presentation/workshop, electronic support, minor environmental modifications, organisational support, and team competition. Assessments will take place at baseline and post-intervention (week 10).


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 20, 2019
Est. primary completion date December 20, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - = 0.6 Full Time Equivalent (FTE) work hours - Ambulatory - Predominantly desk-based (spend on average = 5-h/day seated at work by self-report) - Own a smartphone, with ability to keep phone with them during work hours Exclusion Criteria: - Planned absence of two weeks or more during the intervention period - Work part time (< 0.6 FTE) - Health contraindications to standing and walking - Planned relocation to another site, office or workplace - Have personal access to an active workstation (sit-stand desk, seat cycle, treadmill desk or similar) - Participating simultaneously in another workplace intervention (for sedentary behaviour, physical activity, diet, lifestyle, or combination thereof) - Health contraindications to postural stability testing (e.g., injury to the lower extremities in the past six months, dizziness, or epilepsy)

Study Design


Intervention

Behavioral:
Breaks
3-min breaks every half hour at work

Locations

Country Name City State
United Kingdom University of Bedfordfordshire Bedford Bedfordshire

Sponsors (1)

Lead Sponsor Collaborator
University of Bedfordshire

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility - Adherence: Drop-out rates in control and intervention group Analyses of drop-out rates (%) in control and intervention group. From recruitment (typically 4 weeks prior to baseline) up to study completion (typically 12 weeks)
Primary Feasibility - Acceptability: Perceptions of the intervention Asking participants' to qualitatively reflect on the intervention via semi-structured interview. At week 11
Secondary Change in the number of breaks (sit-stand transitions) from sedentary time per hour (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sit-stand transitions. This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in sitting time accrued in prolonged bouts (= 30 minutes) (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time accrued in prolonged bouts (= 30 minutes). This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in the average duration (minutes) of prolonged sitting bouts (= 30 minutes) (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the average duration (minutes) of prolonged sitting bouts (= 30 minutes). This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in the number of prolonged sitting bouts (= 30 minutes) (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the number of prolonged sitting bouts (= 30 minutes). This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in the total duration (minutes) of sitting time (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time. This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in step count (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of step count. This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in total stepping time (in minutes) (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total stepping time (in minutes). This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Change in total standing time (in minutes) (workplace and daily) Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total standing time (in minutes). This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Secondary Weight (kg) Changes in weight via Tanita scale. Baseline and at week 11
Secondary Body mass index (BMI) Changes in BMI will be computed by dividing participants' weight (in kilograms) by their height (in metres) squared. Baseline and at week 11
Secondary Waist circumference (cm) Changes in waist circumference will be assessed by tape measure. Baseline and at week 11
Secondary Body fat % Changes in body fat percentage will be assessed via a bioelectric impedance spectroscopy device. Baseline and at week 11
Secondary Body fat mass (kg) Changes in body fat mass via a bioelectric impedance spectroscopy device. Baseline and at week 11
Secondary Lean body mass (kg) Changes in lean body mass via a bioelectric impedance spectroscopy device. Baseline and at week 11
Secondary Blood pressure (mmHg) Changes in blood pressure measured via electronic sphygmomanometer. Baseline and at week 11
Secondary Fasted blood cholesterol (mg/dL) Changes in total, high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol measured via fasting blood tests using a Cholestech machine. Baseline and at week 11
Secondary Fasted blood triglycerides (mg/dL) Changes in triglycerides measured via fasting blood tests using a Cholestech machine. Baseline and at week 11
Secondary Fasted blood glucose (mg/dL) Changes in glucose levels measured via fasting blood tests using a Cholestech machine. Baseline and at week 11
Secondary Salivary cortisol (nmol/L) Changes in the cortisol awakening response and diurnal cortisol levels will be assessed via saliva samples (provided by chewing on a cotton swab for 60secs) collected seven times over the course of one day. Baseline and at week 11. At each time point saliva samples will be collected at 7 time points over the course of one day.
Secondary Nordic musculoskeletal questionnaire The Nordic musculoskeletal questionnaire is comprised of 40 forced-choice questions pertaining to low back, neck, shoulder and general physical complaints most often experienced in the work setting. A visual diagram aids the viewer by labelling the nine regions of the body referred to in the questionnaire. Acceptable reliability for this tool has been demonstrated. Baseline and at week 11
Secondary Postural sway velocity (mm/s) Change in postural sway velocity (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan). Baseline and at week 11
Secondary Postural sway range (mm) Change in postural sway range (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan). Baseline and at week 11
Secondary International Physical Activity Questionnaire short form (IPAQ) Changes in self-reported physical activity and total sitting time. The International Physical Activity Questionnaire short form (IPAQ) measures self-reported physical activity and sitting time in the last seven days. Participants are asked to report frequency of participation (0-7 days) and duration of activity on one of those days (in hours and minutes). The IPAQ has demonstrated acceptable reliability and validity in measuring activity in the last seven days. Baseline and at week 11
Secondary Marshall sitting questionnaire The Marshall sitting questionnaire has five questions that measure self-reported domain-specific sitting time (hours and minutes) on weekend days and weekdays. This questionnaire has good reliability and validity for sitting time on weekdays and weekend days. Baseline and at week 11
Secondary Warwick-Edinburgh mental well-being scale (WEMWBS) The Warwick-Edinburgh mental well-being scale (WEMWBS) is a 14-item questionnaire used to assess various aspects of positive mental health (e.g., "I've been feeling optimistic about the future"). Participants are asked to rate their experience of each wellbeing statement between 1 and 5 (1 = none of the time and 5 = all of the time). Item scores are then combined to provide a total score (between 14 - 70). The higher the score the better the overall mental wellbeing. For intervention purposes, a change in the total score of 3-8 points between two time points may be considered a "meaningful change". Baseline and at week 11
Secondary Positive and negative affect schedule (PANAS) Changes in self-reported mood via the positive and negative affect schedule (PANAS) consisting of two 10-item subscales to measure positive and negative affect (i.e., mood). A number of words that describe different feelings and emotions (e.g., "interested", "distressed", "excited") are presented and participants are asked to indicate on a 5-point scale to what extent over the past week they have felt these feelings/emotions (1 = very slightly or not at all and 5 = extremely). These scales are internally consistent with very good convergent and discriminant correlations.
Negative Affect subscale Item scores on the negative affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more negative emotions experienced.
Positive Affect subscale Item scores on the positive affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more positive emotions experienced.
Baseline and at week 11
Secondary Operational police stress questionnaire (PSQ-Op) Changes in ratings of 20 operational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors. Baseline and at week 11
Secondary Organisational police stress questionnaire (PSQ-Org) Changes in ratings of 20 organisational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors. Baseline and at week 11
Secondary Job satisfaction Changes in self-reported job satisfaction and will be evaluated via a single-item questionnaire ("How satisfied are you with your job in general?") assessed on a 7-point Likert scale (1 = dissatisfied and 7 = extremely satisfied). A higher score represents more satisfaction with one's job. Baseline and at week 11
Secondary Job performance Changes in self-reported job performance will be evaluated via a single-item questionnaire ("How well do you think you have performed in your job recently?") with a 7-point Likert scale (1 = very poorly and 7 = extremely well). A higher score represents a more positive assessment of job performance. Baseline and at week 11
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A